Irfan Alibay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irfan Alibay has a total of 159 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Ries
Open Free Energy, Open Molecular Software Foundation, Davis, California 95616, United States
2 shared publications - David L. Mobley
University of California, Irvine
2 shared publications - David W. H. Swenson
Open Free Energy, Open Molecular Software Foundation, Davis, California 95616, United States
2 shared publications - Hannah Baumann
†School of Pharmacy and Pharmaceutical Sciences Irvine ‡Open Free Energy Open Molecular Software Foundation University of California 95616 Davis California United States
2 shared publications - James Rb Eastwood
Open Free Energy, Open Molecular Software Foundation, Davis, California 95616, United States
2 shared publications - John Damon Chodera
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
2 shared publications
Latest Publications
- Open Access
- 6 January 2026
- Published by American Chemical Society (ACS) in ChemRxiv
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data
Computational blind challenges offer critical, unbiased assessment opportunities to assess and accelerate scientific progress, as demonstrated by a breadth of breakthroughs over the last decade. We report the outcomes and key insights from an open science community blind challenge focused on computational methods in drug discovery, using lead optimization data from the AI-driven Structure-enabled Antiviral Platform (ASAP) Discovery Consortium’s pan-coronavirus antiviral discovery program, in partnership with Polaris and the OpenADMET project. This collaborative initiative invited global participants from both academia and industry to develop and apply computational methods to predict the biochemical potency and crystallographic ligand poses of small molecules against key coronavirus targets, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) main protease (Mpro), as well as multiple ADMET assay endpoints, using previously undisclosed comprehensive experimental drug discovery datasets as benchmarks. By evaluating submissions across multiple tasks and compounds, we established performance leaderboards and conducted meta-analyses to assess methodological strengths, common pitfalls, and areas for improvement. This analysis provides a foundation for best practices in real-world machine learning evaluation, grounded in community-driven benchmarking. We also highlight how next-generation platforms, such as Polaris, enable rigorous challenge design, embedded evaluation frameworks, and broad community engagement. This paper reports the collective findings of the challenge, offering a high-level overview of the data, evaluation infrastructure, and top- performing strategies. We further provide context and support for the accompanying papers authored by the challenge participants in this special issue, which explore individual approaches in greater depth. Together, these contributions aim to advance reproducible, trustworthy, and high-impact computational methods in drug discovery, and to explore best practices and pitfalls in future blind challenge design and execution, including planned initiatives for the OpenADMET project.
- 6 January 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessA Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data
Computational blind challenges offer critical, unbiased assessment opportunities to assess and accelerate scientific progress, as demonstrated by a breadth of breakthroughs over the last decade. We report the outcomes and key insights from an open science community blind challenge focused on computational methods in drug discovery, using lead optimization data from the AI-driven Structure-enabled Antiviral Platform (ASAP) Discovery Consortium’s pan-coronavirus antiviral discovery program, in partnership with Polaris and the OpenADMET project. This collaborative initiative invited global participants from both academia and industry to develop and apply computational methods to predict the biochemical potency and crystallographic ligand poses of small molecules against key coronavirus targets, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) main protease (Mpro), as well as multiple ADMET assay endpoints, using previously undisclosed comprehensive experimental drug discovery datasets as benchmarks. By evaluating submissions across multiple tasks and compounds, we established performance leaderboards and conducted meta-analyses to assess methodological strengths, common pitfalls, and areas for improvement. This analysis provides a foundation for best practices in real-world machine learning evaluation, grounded in community-driven benchmarking. We also highlight how next-generation platforms, such as Polaris, enable rigorous challenge design, embedded evaluation frameworks, and broad community engagement. This paper reports the collective findings of the challenge, offering a high-level overview of the data, evaluation infrastructure, and top- performing strategies. We further provide context and support for the accompanying papers authored by the challenge participants in this special issue, which explore individual approaches in greater depth. Together, these contributions aim to advance reproducible, trustworthy, and high-impact computational methods in drug discovery, and to explore best practices and pitfalls in future blind challenge design and execution, including planned initiatives for the OpenADMET project.
- Open Access
- 3 January 2026
- Published by American Chemical Society (ACS) in ChemRxiv
The growing role of open source software in molecular modeling
The increasing importance and predictive power of modern molecular modeling, driven by physics- and machine learning-based methods, necessitates a new collaborative architecture to replace the isolated, traditional model of software development. The traditional approach often led to redundant engineering effort, high costs, and opaque systems that limit reproducibility, independent scrutiny, and scientific independence. This perspective advocates for permissively licensed open source software as a scientific and economic multiplier by reducing the duplication of effort, enabling scientific validation of modeling tools, and frictionless experimentation with new ideas. Coordinated, multi-project consortia, such as Open Force Field, Open Free Energy, OpenFold, and OpenADMET have formed to collaboratively build shared computational infrastructure and release all methods under permissive licenses. The success of these large-scale efforts requires organizational structures that extend beyond code. The Open Molecular Software Foundation (OMSF), a US nonprofit, serves as a domain-specific institutional home and fiscal sponsor. By providing governance, administrative infrastructure, and dedicated research software engineers, OMSF aligns incentives across academic and industrial stakeholders. This framework enables a synergistic ecosystem where projects interoperate to accelerate innovation, eliminate duplication, and ensure long-term software sustainability, thereby creating durable foundations that elevate the entire molecular modeling community.
- 3 January 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessThe growing role of open source software in molecular modeling
The increasing importance and predictive power of modern molecular modeling, driven by physics- and machine learning-based methods, necessitates a new collaborative architecture to replace the isolated, traditional model of software development. The traditional approach often led to redundant engineering effort, high costs, and opaque systems that limit reproducibility, independent scrutiny, and scientific independence. This perspective advocates for permissively licensed open source software as a scientific and economic multiplier by reducing the duplication of effort, enabling scientific validation of modeling tools, and frictionless experimentation with new ideas. Coordinated, multi-project consortia, such as Open Force Field, Open Free Energy, OpenFold, and OpenADMET have formed to collaboratively build shared computational infrastructure and release all methods under permissive licenses. The success of these large-scale efforts requires organizational structures that extend beyond code. The Open Molecular Software Foundation (OMSF), a US nonprofit, serves as a domain-specific institutional home and fiscal sponsor. By providing governance, administrative infrastructure, and dedicated research software engineers, OMSF aligns incentives across academic and industrial stakeholders. This framework enables a synergistic ecosystem where projects interoperate to accelerate innovation, eliminate duplication, and ensure long-term software sustainability, thereby creating durable foundations that elevate the entire molecular modeling community.
- Open Access
- 28 December 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Developing and benchmarking Sage 2.3.0 with the AshGC neural network charge model
We report a new charge model and a new general small molecule force field. Here, we address the development and benchmarking of both the Open Force Field (OpenFF) AshGC charge model, as well as the Sage 2.3.0 small molecule force field for drug-like molecules. AshGC is a graph neural network-based method for efficient assignment of charges to both small and large molecules, designed to produce charges of semi- empirical quality at low cost. We describe the model, its architecture, featurization, training process, and performance. AshGC largely generates charges within the range of other accepted AM1-BCC backends such as OpenEye’s oequacpac and AmberTools’ sqm, but we note areas of poor performance such as in smaller molecules and in charged molecules, as well as areas of chemistry underrepresented in the training set. We fur- ther describe the development and performance of Sage 2.3.0, where Lennard-Jones and valence parameters are re-trained with neural network charges for the first time. Our benchmark suite of common force field tasks ranges from optimizing molecular structures in vacuum to protein-ligand binding free energies. Overall, Sage 2.3.0 performs comparably to previous Sage force fields, although we report minor improvements in the prediction of condensed phase properties and a minor decrease in performance in the prediction of non-aqueous solvation free energies. As with other OpenFF force fields, Sage 2.3.0 was validated in protein-ligand benchmarks to be compatible with Amber protein force fields. All data are publicly available, along with scripts, environments, and complete details for reproducing the training and benchmarking of AshGC and Sage 2.3.0 at https://github.com/openforcefield/ashgc-v1.0-fit and github.com/openforcefield/ash-sage-rc2 respectively.
- 28 December 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessDeveloping and benchmarking Sage 2.3.0 with the AshGC neural network charge model
We report a new charge model and a new general small molecule force field. Here, we address the development and benchmarking of both the Open Force Field (OpenFF) AshGC charge model, as well as the Sage 2.3.0 small molecule force field for drug-like molecules. AshGC is a graph neural network-based method for efficient assignment of charges to both small and large molecules, designed to produce charges of semi- empirical quality at low cost. We describe the model, its architecture, featurization, training process, and performance. AshGC largely generates charges within the range of other accepted AM1-BCC backends such as OpenEye’s oequacpac and AmberTools’ sqm, but we note areas of poor performance such as in smaller molecules and in charged molecules, as well as areas of chemistry underrepresented in the training set. We fur- ther describe the development and performance of Sage 2.3.0, where Lennard-Jones and valence parameters are re-trained with neural network charges for the first time. Our benchmark suite of common force field tasks ranges from optimizing molecular structures in vacuum to protein-ligand binding free energies. Overall, Sage 2.3.0 performs comparably to previous Sage force fields, although we report minor improvements in the prediction of condensed phase properties and a minor decrease in performance in the prediction of non-aqueous solvation free energies. As with other OpenFF force fields, Sage 2.3.0 was validated in protein-ligand benchmarks to be compatible with Amber protein force fields. All data are publicly available, along with scripts, environments, and complete details for reproducing the training and benchmarking of AshGC and Sage 2.3.0 at https://github.com/openforcefield/ashgc-v1.0-fit and github.com/openforcefield/ash-sage-rc2 respectively.
- Open Access
- 11 September 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Konnektor: A framework for using graph theory to plan networks for free energy calculations
Alchemical free energy campaigns can be planned using graph theory by building up networks that contain nodes representing molecules that are connected by possible transformations as edges. We introduce Konnektor, an open-source Python package, for systematically planning, modifying, and analyzing free energy calculation networks. Konnektor is designed to aid in the drug discovery process by enabling users to easily setup free energy campaigns using complex graph manipulation methods. The package contains functions for network operations including concatenation of networks, deletion of transformations, and clustering of molecules, along with a framework for combining these tools with existing network generation algorithms to enable the development of more complex methods for network generation. A comparison of the various network layout features offered is carried out using toy datasets. Additionally, Konnektor contains visualization and analysis tools, making the investigation of network features much simpler. Besides the content of the package, the paper also offers application examples, demonstrating how Konnektor can be used and how the different networks perform from a graph theory perspective. Konnektor is freely available via GitHub at https://github.com/OpenFreeEnergy/konnektor under the permissive MIT License.
- 11 September 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessKonnektor: A framework for using graph theory to plan networks for free energy calculations
Alchemical free energy campaigns can be planned using graph theory by building up networks that contain nodes representing molecules that are connected by possible transformations as edges. We introduce Konnektor, an open-source Python package, for systematically planning, modifying, and analyzing free energy calculation networks. Konnektor is designed to aid in the drug discovery process by enabling users to easily setup free energy campaigns using complex graph manipulation methods. The package contains functions for network operations including concatenation of networks, deletion of transformations, and clustering of molecules, along with a framework for combining these tools with existing network generation algorithms to enable the development of more complex methods for network generation. A comparison of the various network layout features offered is carried out using toy datasets. Additionally, Konnektor contains visualization and analysis tools, making the investigation of network features much simpler. Besides the content of the package, the paper also offers application examples, demonstrating how Konnektor can be used and how the different networks perform from a graph theory perspective. Konnektor is freely available via GitHub at https://github.com/OpenFreeEnergy/konnektor under the permissive MIT License.
- Open Access
- 24 June 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Analysis of protein-glycan recognition using absolute binding free energies
Carbohydrates are key biological mediators of molecular recognition and signalling processes. In this work, we explore the ability of absolute binding free energy (ABFE) calculations to predict the affinities of a set of five related carbohydrate ligands for the lectin protein, concanavalin A, ranging from 27-atom monosaccharides to a 120-atom complex-type N-linked glycan core pentasaccharide. ABFE calculations quantitatively rank and estimate the affinity of the ligands in relation to microcalorimetry, with a mean signed error in binding free energy of -0.63 ± 0.04 kcal/mol. Consequently, the diminished binding efficiencies of the larger carbohydrate ligands are closely reproduced: the ligand efficiency values from isothermal titration calorimetry for the glycan core pentasaccharide and its constituent trisaccharide and monosaccharide compounds are respectively -0.14 ± 0.00, -0.22 ± 0.00 and -0.41 ± 0.00 kcal/mol per heavy atom. ABFE calculations predict these ligand efficiencies to be -0.14 ± 0.02, -0.24 ± 0.03 and -0.46 ± 0.06 kcal/mol per heavy atom respectively. Consequently, the ABFE method correctly identifies the high affinity of the key anchoring mannose residue and the negligible contribution to binding of both β-GlcNAc arms of the pentasaccharide. While challenges remain in sampling the conformation and interactions of these polar, flexible and weakly bound ligands, we nevertheless here find that the ABFE method performs well. The method shows excellent promise as a quantitative tool for predicting and deconvoluting carbohydrate-protein interactions, with potential application to design of therapeutics, vaccines and diagnostics.
- 24 June 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessAnalysis of protein-glycan recognition using absolute binding free energies
Carbohydrates are key biological mediators of molecular recognition and signalling processes. In this work, we explore the ability of absolute binding free energy (ABFE) calculations to predict the affinities of a set of five related carbohydrate ligands for the lectin protein, concanavalin A, ranging from 27-atom monosaccharides to a 120-atom complex-type N-linked glycan core pentasaccharide. ABFE calculations quantitatively rank and estimate the affinity of the ligands in relation to microcalorimetry, with a mean signed error in binding free energy of -0.63 ± 0.04 kcal/mol. Consequently, the diminished binding efficiencies of the larger carbohydrate ligands are closely reproduced: the ligand efficiency values from isothermal titration calorimetry for the glycan core pentasaccharide and its constituent trisaccharide and monosaccharide compounds are respectively -0.14 ± 0.00, -0.22 ± 0.00 and -0.41 ± 0.00 kcal/mol per heavy atom. ABFE calculations predict these ligand efficiencies to be -0.14 ± 0.02, -0.24 ± 0.03 and -0.46 ± 0.06 kcal/mol per heavy atom respectively. Consequently, the ABFE method correctly identifies the high affinity of the key anchoring mannose residue and the negligible contribution to binding of both β-GlcNAc arms of the pentasaccharide. While challenges remain in sampling the conformation and interactions of these polar, flexible and weakly bound ligands, we nevertheless here find that the ABFE method performs well. The method shows excellent promise as a quantitative tool for predicting and deconvoluting carbohydrate-protein interactions, with potential application to design of therapeutics, vaccines and diagnostics.
- Open Access
- 31 October 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Kartograf: An Accurate Geometry-Based Atom Mapper for Hybrid Topology Relative Free Energy Calculations
Relative binding free energy (RBFE) calculations have emerged as a powerful tool supporting ligand optimization in drug discovery. Despite many successes, the use of RBFEs can often be limited by automation problems, in particular the setup of such calculations. Atom mapping algorithms are an essential component in setting up automatic large-scale hybrid topology RBFE calculation campaigns. Traditional algorithms typically employ a 2D subgraph isomorphism solver (SIS) in order to estimate the maximum common substructure (MCS). SIS-based approaches can be limited by time-intensive operations and issues with capturing geometry-linked chemical properties, leading potentially to suboptimal solutions. To overcome these limitations, we have developed Kartograf, a geometric-graph-based algorithm that uses primarily the 3D coordinates of atoms to find a mapping between two ligands. In free energy approaches, the ligand conformations are usually derived from docking or other previous modeling approaches giving the coordinates a certain importance. By considering the spatial relationships between atoms related to the molecule coordinates, our algorithm bypasses the computationally complex subgraph matching of SIS-based approaches and reduces the problem to a much simpler bipartite graph matching problem. Moreover, Kartograf effectively circumvents typical mapping issues induced by molecule symmetry and stereoisomerism, making it a more robust approach for atom mapping from a geometric perspective. To validate our method, we have calculated mappings with our novel approach using a diverse set of small molecules and used the mappings in relative hydration and binding free energies calculations. The comparison with two SIS-based algorithms showed that Kartograf offers a fast alternative approach. The code for Kartograf is freely available on Github (https://github.com/OpenFreeEnergy/kartograf). While developed for the OpenFE ecosystem, Kartograf can also be utilized as a standalone Python package.
- 31 October 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessKartograf: An Accurate Geometry-Based Atom Mapper for Hybrid Topology Relative Free Energy Calculations
Relative binding free energy (RBFE) calculations have emerged as a powerful tool supporting ligand optimization in drug discovery. Despite many successes, the use of RBFEs can often be limited by automation problems, in particular the setup of such calculations. Atom mapping algorithms are an essential component in setting up automatic large-scale hybrid topology RBFE calculation campaigns. Traditional algorithms typically employ a 2D subgraph isomorphism solver (SIS) in order to estimate the maximum common substructure (MCS). SIS-based approaches can be limited by time-intensive operations and issues with capturing geometry-linked chemical properties, leading potentially to suboptimal solutions. To overcome these limitations, we have developed Kartograf, a geometric-graph-based algorithm that uses primarily the 3D coordinates of atoms to find a mapping between two ligands. In free energy approaches, the ligand conformations are usually derived from docking or other previous modeling approaches giving the coordinates a certain importance. By considering the spatial relationships between atoms related to the molecule coordinates, our algorithm bypasses the computationally complex subgraph matching of SIS-based approaches and reduces the problem to a much simpler bipartite graph matching problem. Moreover, Kartograf effectively circumvents typical mapping issues induced by molecule symmetry and stereoisomerism, making it a more robust approach for atom mapping from a geometric perspective. To validate our method, we have calculated mappings with our novel approach using a diverse set of small molecules and used the mappings in relative hydration and binding free energies calculations. The comparison with two SIS-based algorithms showed that Kartograf offers a fast alternative approach. The code for Kartograf is freely available on Github (https://github.com/OpenFreeEnergy/kartograf). While developed for the OpenFE ecosystem, Kartograf can also be utilized as a standalone Python package.